Zhengye Biotechnology Holding (ZYBT) Dividends payables (2023 - 2025)
Zhengye Biotechnology Holding (ZYBT) posted quarterly Dividends payables of $304000.0 for Q2 2025, up 5.7% on a QoQ basis from $287619.7 in Q4 2024.
Zhengye Biotechnology Holding (ZYBT) Dividends payables (2023 - 2025) Analysis & Trends
Zhengye Biotechnology Holding (ZYBT) has reported Dividends payables for 3 consecutive years, with $304000.0 the latest figure, recorded in Q2 2025.
- Quarterly Dividends payables changed N/A year-over-year to $304000.0 in Q2 2025, while the trailing twelve-month figure through Jun 2025 was $304000.0 (changed N/A YoY) and the FY2024 annual result came in at $287619.7, down 86.77% from the prior year.
- Dividends payables climbed to $304000.0 in Q2 2025 per ZYBT's latest filing, from $287619.7 in the prior quarter.
- Over the last five years, Dividends payables for ZYBT reached as high as $2.2 million in Q4 2023 and fell as low as $287619.7 in Q4 2024.
- A 3-year average of $921828.4 and a median of $304000.0 in 2025 frame the typical range for Dividends payables.
- The largest YoY upside for Dividends payables was 86.77% in 2024 against a maximum downside of 86.77% in 2024.
- Year by year, Dividends payables stood at $2.2 million in 2023, then sank by 86.77% to $287619.7 in 2024, then grew by 5.7% to $304000.0 in 2025.
- According to Business Quant data, Dividends payables over the past three periods registered $304000.0, $287619.7, and $2.2 million for Q2 2025, Q4 2024, and Q4 2023 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Dividends payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 224.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | - |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Zhengye Biotechnology Holding | 85.23 Mn | 85.93 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 304,000.00 |
| Dec 31, 2024 | 287,619.68 |
| Dec 31, 2023 | 2.17 Mn |